Rheumatology Program | Research and Innovation

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Our department strives to be a leading source of research and discovery and is actively involved in studies that are improving the way children with inflammatory diseases are treated. Our researchers are involved in: 

  • new immunoregulatory treatments for children with severe arthritis and systemic lupus erythematosus who are unresponsive to routine therapies
  • alternative medications and treatments for children with rheumatologic diseases
  • laboratory studies of the role of the immune system in mediating inflammation in skin and joints, designed to lead to novel approaches for preventing disease
  • research into the causes of Kawasaki disease
  • studies of new pharmacologic and non-pharmacologic approaches to pain control in children
  • new methods of teaching musculoskeletal diagnostic skills to pediatric interns

In addition, Boston Children's is an active participant in the Pediatric Rheumatology Collaborative Study Group, which gives our patients opportunities to participate in national multi-center therapeutic trials.

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337